title: Why pick on propoxyphene? The evidence demands it.
abstract: While propoxyphene may have filled a niche when it was first marketed in 1957, newer, safer agents are now available. Multiple experts list the drug as one to avoid in the elderly patient. Evidence-based practice requires its use be minimized, especially in individuals over the age of 65.
authors.affiliation: Department of Pharmacy Practice at the University of Arkansas for Medical Sciences' College of Pharmacy, USA.
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Hutchison
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D011431:Dextropropoxyphene / Q000008:administration & dosage / Q000009:adverse effects*; D055317:Evidence-Based Practice; D006801:Humans; D009293:Opioid-Related Disorders / Q000517:prevention & control*; D010146:Pain / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000701:Analgesics, Opioid; D011431:Dextropropoxyphene